158 related articles for article (PubMed ID: 19146756)
1. Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors.
Shen X; DeRiemer K; Yuan ZA; Shen M; Xia Z; Gui X; Wang L; Gao Q; Mei J
Int J Tuberc Lung Dis; 2009 Feb; 13(2):253-9. PubMed ID: 19146756
[TBL] [Abstract][Full Text] [Related]
2. Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China.
Wang W; Wang J; Zhao Q; Darling ND; Yu M; Zhou B; Xu B
Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):581-6. PubMed ID: 21174222
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
[TBL] [Abstract][Full Text] [Related]
5. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
[TBL] [Abstract][Full Text] [Related]
6. Spatial pattern of isoniazid-resistant tuberculosis and its associated factors among a population with migrants in China: a retrospective population-based study.
Zhang H; Sun R; Wu Z; Liu Y; Chen M; Huang J; Lv Y; Zhao F; Zhang Y; Li M; Jiang H; Zhan Y; Xu J; Xu Y; Yuan J; Zhao Y; Shen X; Yang C
Front Public Health; 2024; 12():1372146. PubMed ID: 38510351
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Yu HT; Wang Q; Yang N; Li HM; Liang JQ; Liu CH
J Med Microbiol; 2012 Jul; 61(Pt 7):960-967. PubMed ID: 22422574
[TBL] [Abstract][Full Text] [Related]
8. Which urban migrants default from tuberculosis treatment in Shanghai, China?
Chen J; Qi L; Xia Z; Shen M; Shen X; Mei J; DeRiemer K; Zheng'an Yuan
PLoS One; 2013; 8(11):e81351. PubMed ID: 24312292
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
[TBL] [Abstract][Full Text] [Related]
10. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.
Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y
BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878
[TBL] [Abstract][Full Text] [Related]
11. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
12. Epidemiology of drug-resistant tuberculosis in Chongqing, China: A retrospective observational study from 2010 to 2017.
Wu B; Yu Y; Du C; Liu Y; Hu D
PLoS One; 2019; 14(12):e0216018. PubMed ID: 31821321
[TBL] [Abstract][Full Text] [Related]
13. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K
Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Risk Factors of Primary Drug-Resistant Tuberculosis in China.
Wang SF; Zhou Y; Pang Y; Zheng HW; Zhao YL
Biomed Environ Sci; 2016 Feb; 29(2):91-8. PubMed ID: 27003166
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.
Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B
Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239
[TBL] [Abstract][Full Text] [Related]
16. Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status.
Ge E; Li D; Luo M; Tsui KWS; Waye MMY; Shen X; Wei X
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1462-1468. PubMed ID: 30606318
[TBL] [Abstract][Full Text] [Related]
17. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Huang H; Ding N; Yang T; Li C; Jia X; Wang G; Zhong J; Zhang J; Jiang G; Wang S; Zong Z; Jing W; Zhao Y; Xu S; Chen F
Clin Infect Dis; 2019 Jul; 69(3):405-413. PubMed ID: 30321294
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
